Is Drug Utilization in Greece Sex dependent? A Population-based Study

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 1, 2013, Pages 55-62

  Athanasopoulos, Charalampos ^a   Pitychoutis, Pothitos M ^a,b   Messari, Ioanna ^a   Lionis, Christos ^c   Papadopoulou Daifoti, Zeta ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c INSTITUT DU FER À MOULIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTITHYROID AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; GREECE; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MALE; MORBIDITY; OSTEOPOROSIS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIOECONOMICS;

ADULT; AGED; AGED, 80 AND OVER; DRUG THERAPY; FEMALE; GREECE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS;

EID: 84871117386     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00920.x     Document Type: Article

References (86)

1. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007;370:1929-38.
2. Meetoo D. Chronic diseases: the silent global epidemic. Br J Nurs 2008;17:1320-5.
3. WHO. World health statistics. World Health Organization 2009. Available at: http://www.who.int/whosis/whostat/EN_WHS09_Full.pdf.
4. WHO. Women and health. World Health Organization 2009. Available at: http://whqlibdoc.who.int/publications/2009/9789241563857_eng.pdf.
5. E.U. The health status of the European Union. Narrowing the health gap. European Commission 2003. Available at:http://ec.europa.eu/health/archive/ph_information/documents/health_status_en.pdf.
6. Hopman WM, Harrison MB, Coo H, Friedberg E, Buchanan M, VanDenKerkhof EG. Associations between chronic disease, age and physical and mental health status. Chronic Dis Can 2009; 29:108-16.
7. Kadam UT, Schellevis FG, Lewis M, van derWindtDA, de VetHC, Bouter LM et al. Does age modify the relationship between morbidity severity and physical health in English and Dutch family practice populations? Qual Life Res 2009;18:209-20.
8. Stemper BD, Yoganandan N, Pintar FA, Maiman DJ, Meyer MA, DeRosia J et al. Anatomical gender differences in cervical vertebrae of size-matched volunteers. Spine (Phila Pa 1976) 2008;33:E44-9.
9. Sizer PS, James CR. Considerations of sex differences in musculoskeletal anatomy. The Active Female 2008;I:25-54.
10. Blair ML. Sex-based differences in physiology: what should we teach in the medical curriculum? Adv Physiol Educ 2007;31:23-5.
11. Uhl K. Advancing women's health in the 21st century: applying the tools of clinical pharmacology. Clin Pharmacol Ther 2008;83:3-7.
12. Van der Heyden JHA, Gisle L, Hesse E, Demarest S, Drieskens S, Tafforeau J. Gender differences in the use of anxiolytics and antidepressants: a population based study. Pharmacoepidemiol Drug Saf 2009;18:1101-10.
13. Athanasakis C, Karela A, Karampli E, Kuriopoulos I, Lionis H, Mylona K et al. The role of local governments on public health. Institute of Local Government: Athens 2009. (http://www.ita.org.gr/library/Downloads/docs/090526090526)
14. Thümmler K, Britton A, Kirch W. Data and Information on Women's Health in the European Union. European Communities 2009. Available at: http://ec.europa.eu/health/population_groups/docs/women_report_en.pdf.
15. Kaló Z, Docteur E, Moïse P. Pharmaceutical Pricing and reimbursement policies in Slovakia, Organisation for Economic Co-operation and Development (OECD) 2008. Available at: http://www.oecd.org/health/healthpoliciesanddata/40177050.pdf.
16. Janι-Llopis E, Gabilondo A. Mental Health in Older People. Consensus paper. European Communities: Luxembourg 2008.
17. Lyons AC, Willott SA. Alcohol consumption, gender identities and women's changing social positions. Sex Roles 2008;59:694-712.
18. Wang Y, Beydoun MA. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6-28.
19. Eggen AE. Pattern of drug use in a general population-prevalence and predicting factors: the Tromsø study. Int J Epidemiol 1994;23:1262-72.
20. Daban F, Pasarín MI, Rodríguez-Sanz M, García-Altés A, Villalbí JR, Zara C et al. Social determinants of prescribed and non-prescribed medicine use. Int J Equity Health 2010;9:12.
21. Koutis AD, Isacsson A, Lindholm LH, Lionis CD, Svenninger K, Fioretos M. Use of primary health care in Spili, Crete, and in Dalby, Sweden. Scand J Prim Health Care 1991;4:297-302.
22. Vitsou E. The medicine market in Greece: Annual Report 2009. Foundation For Economic & Industrial Research (FFEIR) 2009. Available at: http://www.iobe.gr/media/farmaca/farmaco09.pdf.
23. Kousoulakou H, Vitsou E. The medicine market in Greece: Annual Report 2008. Foundation For Economic & Industrial Research (FFEIR) 2008. Available at: http://www.iobe.gr/media/farmaca/farmako2008.pdf.
24. Brooks R, Rabin R, de Charro F, (eds). The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. Kluwer Academic Publishers, Dordrecht, Netherlands, 2003.
25. Parloff MB, Kelman HC, Frank JD. Comfort, effectiveness, and self-awareness as criteria for improvement in psychotherapy. Am J Psychiatry 1954;3:343-51.
26. Lesher EL, Berryhill JS. Validation of the geriatric depression scale-short form among inpatients. J Clin Psychol 1994;50:256-60.
27. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
28. Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Ger Intern Med 1993;8:278-88.
29. Linton A, Garber M, Fagan NK, Peterson MR. Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older. J Manag Care Pharm 2007;13:155-62.
30. Minas M, Koukosias N, Zintzaras E, Kostikas K, Gourgoulianis KI. Prevalence of chronic diseases and morbidity in primary health care in central Greece: an epidemiological study. BMC Health Serv Res 2010;10:252-60.
31. Antonopoulou M, Antonakis N, Hadjipavlou A, Lionis C. Patterns of pain and consulting behaviour in patients with musculoskeletal disorders in rural Crete, Greece. Fam Pract 2007;24:209-16.
32. Papadopoulos FC, Petridou E, Argyropoulou S, Kontaxakis V, Dessypris N, Anastasiou A et al. Prevalence and correlates of depression in late life: a population based study from a rural Greek town. Int J Geriatr Psychiatry 2005;4:350-7.
33. Rollman GB, Lautenbacher S. Sex differences in musculoskeletal pain. Clin J Pain 2001;17:20-4.
34. Peterlin BL, Gupta S, Ward TN, Macgregor A. Sex matters: evaluating sex and gender in migraine and headache research. Headache 2011;51:839-42.
35. Smith FW, Smith PA, Maffulli N. Musculoskeletal differences between males and females. Sports Med Arthrosc 2002;10:98-100.
36. Karasik D, Kiel DP. Genetics of the musculoskeletal system: a pleiotropic approach. J Bone Miner Res 2008;23:788-802.
37. Isacson D, Bingefors K. Epidemiology of analgesic drug use: a gender perspective. Eur J Anaesthesiol 2002;19:5-15.
38. Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use pattern. Ann Pharmacother 2002;36:30-9.
39. Hargreave M, Andersen TV, Nielsen A, Munk C, Liaw KL, Kjaer SK. Factors associated with a continuous regular analgesic use - a population-based study of more than 45, 000 Danish women and men 18-45 years of age. Pharmacoepidemiol Drug Saf 2010;19:65-74.
40. Antonov KI, Isacson DG. Prescription and nonprescription analgesic use in Sweden. Ann Pharmacother 1998;32:485-94.
41. Fernández-Liz E, Modamio P, Catalán A, Lastra CF, Rodríguez T, Mariño EL. Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain. Br J Clin Pharmacol 2008;65:407-17.
42. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2005;2:137-45.
43. Dao TT, LeResche L. Gender differences in pain. J Orofac Pain 2000;14:169-84.
44. Berkley KJ. Sex differences in pain. Behav Brain Sci 1997;20:371-80.
45. Rollman GB, Abdel-Shaheed J, Gillespie JM, Jones KS. Does past pain influence current pain: biological and psychosocial models of sex differences. Eur J Pain 2004;8:427-33.
46. Robinson ME, Riley JL III, Myers CD, Papas RK, Wise EA, Waxenberg LB et al. Gender role expectations of pain: relationship to sex differences in pain. J Pain 2001;2:251-7.
47. Jorgensen TM, Isacson DG, Thorslund M. Prescription drug use among ambulatory elderly in a Swedish municipality. Ann Pharmacother 1993;27:1120-5.
48. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004;420:55-64.
49. Morabia A, Fabre J, Dunand JP. The influence of patient and physician gender on prescription of psychotropic drugs. J Clin Epidemiol 1992;45:111-6.
50. Ufer M, Meyer SA, Junge O, Selke G, Volz HP, Hedderich J et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007;16:1153-60.
51. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998;51:273-83.
52. Bekker MH, van Mens-Verhulst J. Anxiety disorders: sex differences in prevalence, degree, and background, but gender-neutral treatment. Gend Med 2007;4:178-93.
53. Klose M, Jacobi F. Can gender differences in the prevalence of mental disorders be explained by sociodemographic factors? Arch Womens Ment Health 2004;7:133-48.
54. Robinson JA, Sareen J, Cox BJ, Bolton JM. Correlates of self-medication for anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Nerv Ment Dis 2009;197:873-8.
55. Klemenc-Ketis Z, Hladnik Z, Kersnik J. A cross sectional study of sex differences in self-medication practices among university students in Slovenia. Coll Antropol 2011;35:329-34.
56. Fulton MM, Riley EA. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005;17:123-32.
57. Pitychoutis PM, Zisaki A, Dalla C, Papadopoulou-Daifoti Z. Pharmacogenetic insights into depression and antidepressant response: does sex matter? Curr Pharm Des 2010;16:2214-23.
58. Vigod SN, Stewart DE. Emergent research in the cause of mental illness in women across the lifespan. Curr Opin Psychiatry 2009;22:396-400.
59. Stewart DE, Ashraf IJ, Munce SE. Women's mental health: a silent cause of mortality and morbidity. Int J Gynaecol Obstet 2006;94:343-9.
60. Bird CE, Rieker PP. Gender matters: an integrated model for understanding men's and women's health. Soc Sci Med 1999;48:745-55.
61. Mazza D, Dennerstein L. Psychotropic drug use by women: could violence account for the gender difference? J Psychosom Obstet Gynaecol 1996;17:229-34.
62. Thomson M, Smith WA. Prescribing benzodiazepines for noninstitutionalized elderly. Can Fam Physician 1995;41:792-8.
63. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999;19:132-40.
64. Pitychoutis PM, Papadopoulou-Daifoti Z. Of depression and immunity: does sex matter? Int J Neuropsychopharmacol 2010;13:675-89.
65. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 2003;289:3095-105.
66. Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z. Sex differences in the neurobiological substrate of depression and antidepressant response. Basic Clin Pharmacol Toxicol 2010;106:226-33.
67. Tountas J, Karnaki P, Pavi E, Papadopoulou N, Souliotis C, Touloumi G et al. Health Status of the Greek Population, 1986-2006. Publishing House Papazisis, Athens, Greece, 2009.
68. Gorman JM. Gender differences in depression and response to psychotropic medication. Gend Med 2006;3:93-109.
69. Akhtar-Danesh N, Landeen J. Relation between depression and sociodemographic factors. Int J Ment Health Syst 2007;1:4.
70. Helgason T, Tómasson K, Zoega T. Prevalence and distribution of antidepressant, anxiolytic and hypnotic use in 2001. Laeknabladid 2003;89:15-22.
71. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010;67:220-9.
72. Devold HM, Doung GM, Tverdal A, Furu K, Meyer HE, Falch JA et al. Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. Eur J Clin Pharmacol 2010;66:299-306.
73. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D. Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 2007;18:77-84.
74. Cawthon PM. Gender differences in osteoporosis and fractures. Clin Orthop Relat Res 2011;469:1900-5.
75. Gill JM, Hoffman MK. Prevention and treatment of osteoporosis in primary care offices. J Womens Health (Larchmt) 2003;12:473-80.
76. Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R et al. Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Inves 2005;28:101-4.
77. Furu K, Straume B, Thelle DS. Legal drug use in a general population: association with gender, morbidity, health care utilization, and lifestyle characteristics. J Clin Epidemiol 1997;50:341-9.
78. Mitrou P, Raptis SA, Dimitriadis G. Thyroid disease in older people. Maturitas 2011;70:5-9.
79. Wills P, Fastbom J, Claesson CB, Cornelius C, Thorslund M, Winblad B. Use of cardiovascular drugs in an older Swedish population. J Am Geriatr Soc 1996;44:54-60.
80. Mayer O Jr, Simon J, Heidrich J, Cokkinos DV, De Bacquer D, EUROASPIRE II Study Group. Educational level and risk profile of cardiac patients in the EUROASPIRE II substudy. J Epidemiol Community Health 2004;58:47-52.
81. Schmidt AC, Bramlage P, Lichtenthal A, Eckert M, Scholze J. Socio-economic status and the therapeutic effectiveness of antihypertensive treatment - the design of the LEO study. Curr Med Res Opin 2007;23:1987-95.
82. Belkic KL, Landsbergis PA, Schnall PL, Baker D. Is job strain a major source of cardiovascular disease risk? Scand J Work Environ Health 2004;30:85-128.
83. Jordan J, Schlaich M, Redon J, Narkiewicz K, Luft FC, Grassi G et al. European society of hypertension working group on obesity: obesity drugs and cardiovascular outcomes. J Hypertens 2011;29:189-93.
84. Kannel WB, Wilson PWF. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
85. Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the national health and nutrition examination survey 1999-2004. Am J of Hypertens 2008;21:789-98.
86. Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation 2006;113:213-21.